HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zuhal Yapici Selected Research

Subacute Sclerosing Panencephalitis (SSPE)

1/2021Immune alterations in subacute sclerosing panencephalitis reflect an incompetent response to eliminate the measles virus.
12/2014A decrease of regulatory T cells and altered expression of NK receptors are observed in subacute sclerosing panencephalitis.
10/2014Granzyme B gene polymorphism associated with subacute sclerosing panencephalitis.
10/2007Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients.
12/2005Alterations in cell-mediated immune response in subacute sclerosing panencephalitis.
10/2005Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zuhal Yapici Research Topics

Disease

9Tuberous Sclerosis (Bourneville's Disease)
12/2021 - 06/2005
8Seizures (Absence Seizure)
12/2021 - 09/2011
6Subacute Sclerosing Panencephalitis (SSPE)
01/2021 - 10/2005
4Epilepsy (Aura)
12/2021 - 06/2005
4Drug Resistant Epilepsy
12/2019 - 07/2007
3Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022 - 01/2013
3Dystonia (Limb Dystonia)
01/2020 - 01/2005
3Intellectual Disability (Idiocy)
05/2017 - 10/2009
2Leukoencephalopathies
09/2020 - 09/2014
2Inborn Genetic Diseases (Disease, Hereditary)
12/2019 - 01/2019
2Disease Progression
01/2019 - 03/2014
2Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
01/2019 - 03/2017
2Autism Spectrum Disorder
05/2017 - 10/2009
2Partial Epilepsies (Epilepsy, Partial)
10/2016 - 03/2016
2Ataxia (Dyssynergia)
01/2016 - 12/2014
2Movement Disorders (Movement Disorder)
01/2016 - 01/2013
1Auditory neuropathy
03/2022
1Brown-Vialetto-Van Laere syndrome
03/2022
1Aromatic amino acid decarboxylase deficiency
01/2021
1autosomal recessive Segawa syndrome
01/2021
1Neutropenia
01/2019
1Iron Deficiencies
01/2019
1Cognitive Dysfunction
11/2018
1Brain Diseases (Brain Disorder)
11/2018
1Stomatitis
05/2017
1Astrocytoma (Pilocytic Astrocytoma)
05/2017
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
05/2017
1Autistic Disorder (Autism)
05/2017
1Constipation
05/2017
1Angiomyolipoma
05/2017
1Neoplasms (Cancer)
05/2017
1Temporal Lobe Epilepsy
10/2016
1Hippocampal Sclerosis
10/2016
1Encephalitis (Encephalitis, Rasmussen)
03/2016
1Neuroacanthocytosis
01/2015
1Cytochrome-c Oxidase Deficiency
09/2014
1Mitochondrial Diseases (Mitochondrial Disease)
09/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2012
1Schizophrenia (Dementia Praecox)
10/2009
1Idiopathic Generalized Epilepsy
10/2009
1Chromosome 15q13.3 Microdeletion Syndrome
10/2009
1Pain (Aches)
10/2007
1Atrophy
07/2007
1Hypothyroidism
04/2006
1Acquired Immunodeficiency Syndrome (AIDS)
01/2005
1Edema (Dropsy)
09/2002

Drug/Important Bio-Agent (IBA)

6EverolimusFDA Link
12/2021 - 10/2016
5trans-sodium crocetinate (crocetin)IBA
12/2021 - 07/2007
3CytokinesIBA
01/2021 - 10/2005
3Interleukin-10 (Interleukin 10)IBA
01/2021 - 10/2005
3IronIBA
01/2020 - 01/2013
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2018 - 03/2016
3Pharmaceutical PreparationsIBA
05/2017 - 01/2005
3Interleukin-12 (IL 12)IBA
10/2007 - 10/2005
3Protons (Proton)IBA
07/2007 - 09/2002
2Interleukin-2 (IL2)IBA
01/2021 - 10/2007
2TOR Serine-Threonine KinasesIBA
05/2017 - 10/2016
2Proteins (Proteins, Gene)FDA Link
01/2016 - 12/2005
2Glucose (Dextrose)FDA LinkGeneric
10/2012 - 10/2007
1Riboflavin (Vitamin B2)FDA LinkGeneric
03/2022
1beta 2-Glycoprotein I (Apolipoprotein H)IBA
01/2021
1Oligodendrocyte-Myelin GlycoproteinIBA
01/2021
1Apolipoproteins D (Apo D)IBA
01/2021
1Lactic Acid (Lactate)FDA LinkGeneric
09/2020
1Chelating AgentsIBA
01/2019
1SolutionsIBA
01/2019
1DeferiproneIBA
01/2019
1AutoantibodiesIBA
11/2018
1AntibodiesIBA
11/2018
1CholesterolIBA
05/2017
1Triglycerides (Triacylglycerol)IBA
05/2017
1pantothenate kinaseIBA
03/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2016
1Amino AcidsFDA Link
01/2016
1Phosphotransferases (Kinase)IBA
01/2015
1NK Cell Lectin-Like Receptor Subfamily CIBA
12/2014
1Granzymes (Granzyme)IBA
10/2014
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
09/2014
1Mitochondrial Proteins (Mitochondrial Protein)IBA
09/2014
1Carbamazepine (Tegretol)FDA LinkGeneric
09/2011
1Immunoglobulin E (IgE)IBA
10/2009
1CarbohydratesIBA
10/2007
1Sucrose (Saccharose)IBA
10/2007
1InterleukinsIBA
10/2007
1InterferonsIBA
10/2007
1Interferon-gamma (Interferon, gamma)IBA
10/2007
13' Untranslated Regions (3' UTR)IBA
10/2007
1Growth Hormone (Somatotropin)IBA
04/2006
1GonadotropinsIBA
04/2006
1Adrenocorticotropic Hormone (ACTH)FDA Link
04/2006
1VaccinesIBA
12/2005
1Tuberculin (PPD)IBA
12/2005
1AntigensIBA
12/2005
1Interleukin-8 (Interleukin 8)IBA
10/2005

Therapy/Procedure

7Therapeutics
12/2021 - 01/2005
2Transcranial Direct Current Stimulation
10/2016 - 03/2016
1Immunotherapy
11/2018